Categories AlphaGraphs, Earnings, Health Care
Bristol Myers (BMY) stock gains after Q4 results beat Street view
Bristol-Myers Squibb Company (NYSE: BMY) Thursday reported stronger-than-expected fourth-quarter results. The company’s stock gained in the pre-market session soon after the announcement.

The pharmaceutical company reported a 39% growth in fourth-quarter revenue of $11.1 billion, which surpassed Wall Street’s consensus forecast. Consequently, adjusted earnings rose 20% annually to $1.46 per share from $1.22 per share in the fourth quarter of 2019.
On an unadjusted basis, it was a net loss of $10.0 billion or $4.45 per share, compared to a loss of $1.1 billion or $0.55 per share last year.
Read management/analysts’ comments on Bristol Myers’ Q4 report
BMY shares gained 1% immediately after the announcement early Thursday. The stock had closed the previous session lower.
Most Popular
Earnings Preview: What to look for when Netflix (NFLX) reports Q4 2025 results
Netflix, Inc. (NASDAQ: NFLX) is expected to report Q4 results on January 20, amid expectations for strong revenue and earnings growth. The company is navigating a shifting streaming landscape where
What to look for when United Airlines (UAL) reports its Q4 2025 earnings results
Shares of United Airlines (NASDAQ: UAL) stayed red on Thursday. The stock has gained 15% over the past three months. The airline is scheduled to report its earnings results for
Infographic: How Constellation Brands (STZ) performed in Q3 2026
Constellation Brands, Inc. (NYSE: STZ) reported net sales of $2.22 billion for the third quarter of 2026, down 10% year-over-year. Organic net sales were down 2%. Net income attributable to



